|
| Press Releases |
|
 |
|
| Thursday, June 29, 2023 |
|
|
BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development |
| BioMed X, a German independent research institute, announces the start of its first research project in collaboration with Sanofi: "Next Generation Virtual Patient Engine for Clinical Translation of Drug Candidates" (VPE). more info >> |
|
| Thursday, April 27, 2023 |
|
|
BioMed X Launches XSeed Labs in the US with Boehringer Ingelheim - a New Model for Building an External Innovation Ecosystem on an Industry Campus |
| BioMed X announced today the expansion of its collaboration with Boehringer Ingelheim with the launch of a new model for biomedical research: XSeed Labs. more info >> |
|
|
BioMed X Launches XSeed Labs in the US with Boehringer Ingelheim - a New Model for Building an External Innovation Ecosystem on an Industry Campus |
| BioMed X announced today the expansion of its collaboration with Boehringer Ingelheim with the launch of a new model for biomedical research: XSeed Labs. more info >> |
|
| Tuesday, April 4, 2023 |
|
|
BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies |
| BioMed X, an independent biomedical research institute, announces the start of its new research project - "New Strategies to Enhance the Immunogenicity of Tumors" - in collaboration with Merck. The focus of this new research group will be to develop novel approaches for enhancing tumor immunogenicity to broaden the population of patients who could benefit from cancer immunotherapy. more info >> |
|
|
BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies |
| BioMed X, an independent biomedical research institute, announces the start of its new research project - "New Strategies to Enhance the Immunogenicity of Tumors" - in collaboration with Merck. The focus of this new research group will be to develop novel approaches for enhancing tumor immunogenicity to broaden the population of patients who could benefit from cancer immunotherapy. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
AsiaMedic Reports 26% Revenue Growth to S$16.6 million in 1H2025, Led by Strong Diagnostic Imaging Performance
Aug 14, 2025 21:22 HKT/SGT
|
|
|
The 35th Food Expo opens today
Aug 14, 2025 20:05 HKT/SGT
|
|
|
Yuexiu REIT Maintains Overall Operational Stability, Achieves Revenue of Over RMB966 Million
Aug 14, 2025 19:15 HKT/SGT
|
|
|
越秀房产基金整体经营稳定 实现收入逾人民币9.66亿元
Aug 14, 2025 18:42 HKT/SGT
|
|
|
越秀房產基金整體經營穩定 實現收入逾人民幣9.66億元
Aug 14, 2025 17:43 HKT/SGT
|
|
|
Formerra Becomes North American Distributor for Syensqo PVDF
Aug 14, 2025 17:34 HKT/SGT
|
|
|
China Lilang Announces 2025 Interim Results
Aug 14, 2025 17:32 HKT/SGT
|
|
|
Cryofocus Medtech Achieves Record Interim Results with 162% Revenue Surge Driven by Respiratory Intervention Products
Aug 14, 2025 17:32 HKT/SGT
|
|
|
GEON Performance Solutions Achieves Great Place to Work Recognition Globally Second Year in a Row
Aug 14, 2025 17:31 HKT/SGT
|
|
|
NMPA Accepted Essex's Biologics License Application for EB12-20145P (HLX04-O) for the Treatment of Wet Age-Related Macular Degeneration
Aug 14, 2025 17:17 HKT/SGT
|
|
|
Everest Medicines' New Drug Application for Etrasimod Accepted in Taiwan, Marking Another Milestone in Asia Market Access
Aug 14, 2025 17:12 HKT/SGT
|
|
|
雲頂新耀維長寧（艾曲莫德）在中國台灣新藥上市申請獲受理 亞洲市場准入再迎里程碑
Aug 14, 2025 17:12 HKT/SGT
|
|
|
云顶新耀维长宁（艾曲莫德）在中国台湾新药上市申请获受理 亚洲市场准入再迎里程碑
Aug 14, 2025 17:12 HKT/SGT
|
|
|
MMG Announces 2025 Interim Results, Profit, Earnings and Cash up on Strong Copper Growth
Aug 14, 2025 15:27 HKT/SGT
|
|
|
Shoucheng Joins World Humanoid Robot Games - 88 Spectators Invited
Aug 14, 2025 15:25 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
